A new UCLA-led study suggests that advanced genome editing technology could be used as a one-time treatment for the rare and deadly genetic disease CD3 delta severe combined immunodeficiency. The ...
CD7 is an attractive target for chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory T-cell acute lymphoblastic leukemia (ALL). Supportive results of first-in-human studies of base ...
RAND's study provides greater detail on the rates of sexual assault and misconduct across the Army, a chronic problem. WASHINGTON -- Female soldiers at Army bases in Texas, Colorado, Kansas and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results